Javascript is disabled in your browser

Startbase requires Javascript in order to display content.
Please check your browser settings and enable Javascript-Support for this website.

seed

News profitize raises 1.4 million euros for hospitality Less flying blind: platform brings real-time transparency to hotel finances. South Tyrolean startup profitize is growing rapidly.

Marc Nemitz 05.05.2026

News Primogene raises 4.1 million euros for industrial breast milk molecules Biotech from Leipzig makes ingredients from breast milk scalable for the first time. Enzyme tech could change markets from infant formula to pharmaceuticals.

Marc Nemitz 29.04.2026

News VREY secures EUR 3.3 million in seed financing to scale solar power for multi-family homes The Berlin start-up brings photovoltaics directly into the urban housing stock. Vrey is already active in over 200 buildings.

Marc Nemitz 23.04.2026

News Exergy3 receives EUR 11.5 million for up to 1,200 °C Exergy3 secures an 11.5 million euro seed and brings its clean-tech solution to Germany. Munich becomes the new European hub.

Marc Nemitz 21.04.2026

News EVANIUM secures 2.2 million euros for bioavailability of natural substances EVANIUM raises 2.2 million euros for nutraceutical technology. OPTISOLV improves the bioavailability of active ingredients many times over.

Marc Nemitz 15.04.2026

News Graftcode raises 2.1 million euros Start-up wants to make APIs and middleware completely superfluous. With fresh capital, the company is focusing on AI-native software architectures and rapid scaling.

Marc Nemitz 14.04.2026

News Cellbricks Therapeutics raises 10 million euros for bio-printed tissues Cellbricks drives living implants towards the clinic. From tissue engineering to organs, the biotech start-up is scaling up.

Marc Nemitz 25.03.2026

News Finnish deep-tech start-up Elea & Lili raises 2.5 million euros for fossil-free superabsorbers The startup Elea & Lili wants to replace fossil superabsorbents in diapers and agriculture.

Marc Nemitz 18.03.2026

News NRW.BANK invests in iDEL Therapeutics iDEL Therapeutics raises 9 million euros for new approaches in cancer therapy. The technology is designed to transport active substances specifically into cancer cells and reduce side effects.

Marc Nemitz 18.03.2026

News Level Nine has completed 4 million seed With new catalysts, Level Nine initially wants to address the polyurethane market, which is worth more than 100 billion euros.

Marc Nemitz 17.03.2026

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22